CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review

Journal of NeuroVirology

Volumn 20, Issue 5, 2014, Pages 531-537

  Delgado, Silvia R ^a   Maldonado, Janice ^a   Rammohan, Kottil W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

CNS demyelinating disorders; HIV; Human immunodeficiency virus; MS; Multiple sclerosis; Neuromyelitis optica; NMO

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; ATAZANAVIR; CORTICOSTEROID; EMTRICITABINE; GADOLINIUM; METHYLPREDNISOLONE; MYELIN BASIC PROTEIN; PREDNISONE; RITONAVIR; TENOFOVIR;

ADULT; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; CONTRAST ENHANCEMENT; DISEASE DURATION; EARLY DIAGNOSIS; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; MIDDLE AGED; MIDDLE CEREBELLAR PEDUNCLE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; POLYMERASE CHAIN REACTION; SYSTEMATIC REVIEW (TOPIC); TENDON REFLEX; TREATMENT DURATION; VIRUS LOAD; VISUAL ACUITY; VISUAL IMPAIRMENT; COMPLICATION; DEMYELINATING DISEASE; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; PATHOLOGY; PATHOPHYSIOLOGY; VIROLOGY;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEMYELINATING AUTOIMMUNE DISEASES, CNS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED;

EID: 84910154714     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-014-0260-8     Document Type: Article

References (20)

1. (2008) Isentress Drug Approval Package. U.S. Food and Drug Administration (FDA). February 22
2. (2012) CDC. HIV surveillance supplemental report. 17(4)
3. Araujo A, Hall W (2004) Human T-lymphotropic virus type II and neurological disease. Ann Neurol 56:10–19
4. Berger JR, Sheremata WA, Resnick L, Atherton S, Fletcher MA, Norenberg M (1989) Multiple sclerosis-like illness occurring with human immunodeficiency virus infection. Neurology 39:324–329
5. Berger JR, Tornatore C, Major EO, Bruce J, Shapshak P, Yoshioka M, Houff S, Sheremata W, Horton GF, Landy H (1992) Relapsing and remitting human immunodeficiency virus-associated leukoencephalomyelopathy. Ann Neurol 31:34–38
6. Blanche P, Diaz E, Gombert B, Sicard D (2000) Devic’s neuromyelitis optica and HIV-1 infection. Letters to the Editor. J NeurolNeurosurg. Psychiatry 68:795
7. Duran E, Galvez J, Patrignani G, Izquierdo G (2004) Multiple sclerosis-like illness in a HIV-1 patient. J Neurol 251:1142–1144
8. Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, Khaleeli Z, Schmierer K, Miller DH, Giovannoni G (2009) Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 73(1):32–38. doi:10.1212/WNL.0b013e3181aa29fe
9. Feyissa A, Singh P, Smith R (2013) Neuromyelitis optica in the setting of human immunodeficiency virus infection. Poster presented at: CMSC meeting; 2013 May 29- Jun 1; Orlando, Florida
10. Giovannoni G: Raltegravir (Isentress) Pilot study in relapsing multiple sclerosis (INSPIRE). 2013. http://clinicaltrials.gov
11. Hicks C, Gulick RM (2009) Raltegravir: The first HIV type 1 integrase inhibitor. Clin Infect Dis 48(7):931–939. doi:10.1086/597290
12. Krumbholz M, Derfuss T, Hohlfeld R, Meinl E (2012) B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol 8:613–623
13. Maimone D, Annuziata P, Cioni C, Leonardi A, Guazzi GC (1994) Intrathecal synthesis of anti-myelin basic protein IgG in HIV-1+ patients. Acta Neurol Scand 90(4):285–292
14. Martinez-Maza O, Crabb Breen E (2002) B-cell activation and lymphoma in patients with HIV. Opin Oncol 14:528–532
15. Maruszak H, Gold J, Brew BJ, Giovannoni G, Gold J (2011) Could antiretroviral drugs be effective in multiple sclerosis? A case report. Eur J Neurol 18:e110–e111
16. Nagase H, Agematsu K, Kitano K, Takamoto M, Okubo Y, Komiyama A, Sugane K (2001) Mechanism of hypergammaglobulinemia by HIV infection: circulating memory B-cell reduction with plasmacytosis. Clin Immunol 100(2):250–259
17. Narciso P, Galgani S, Del Grosso B, De Marco M, De Santis A, Balestra P, Ciapparoni V, Tozzi V (2001) Acute disseminated encephalomyelitis as manifestation of primary HIV infection. Neurology 57:1493–1496
18. Nissen K, Laska M, Hansen B, Terkelsen T, Villesen P, Bahrami S, Petersen T, Pedersen F, Nexø B (2013) Endogenous retroviruses and multiple sclerosis—new pieces to the puzzle. BMC Neurol 13:111, http://www.biomedcentral.com/1471-2377/13/111
19. Sardar P, Guha P, Roy D, Bandyopadhyay D, Chatterjee SK (2011) Multiple Sclerosis like demyelination in early HIV infection-A rare presentation: case report and literature review. J AIDS Clinic Res 2:4
20. Trujillo JR, McLane M, Lee T, Essex M (1993) Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins. J Virol 67(12):7711–7715